Fingerprint
Dive into the research topics of 'Docetaxel for malignant mesothelioma: Phase II study of the Eastern Cooperative Oncology Group'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Docetaxel for malignant mesothelioma: Phase II study of the Eastern Cooperative Oncology Group
Chandra P. Belani, Sudeshna Adak, Seena Aisner, Philip J. Stella, Nathan Levitan, David H. Johnson
Research output: Contribution to journal › Article › peer-review
14
Scopus
citations